Literature DB >> 4944206

Malignant lymphomas in transplantation patients.

I Penn, W Hammond, L Brettschneider, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4944206      PMCID: PMC2845467     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

1.  Effects of antilymphocyte serum on virus oncogenesis.

Authors:  A C Allison; L W Law
Journal:  Proc Soc Exp Biol Med       Date:  1968-01

2.  Immunologic rejection of human cancer transplanted with a renal allograft.

Authors:  R E Wilson; E B Hager; C L Hampers; J M Corson; J P Merrill; J E Murray
Journal:  N Engl J Med       Date:  1968-02-29       Impact factor: 91.245

Review 3.  "Immunologic" oncogenesis.

Authors:  P J Fialkow
Journal:  Blood       Date:  1967-09       Impact factor: 22.113

Review 4.  Progress in clinical renal homotransplantation.

Authors:  D M Hume
Journal:  Adv Surg       Date:  1966

5.  Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice.

Authors:  T P Casey
Journal:  Clin Exp Immunol       Date:  1968-05       Impact factor: 4.330

6.  Increased incidence of lymphoma after injections of mice with cells differing at weak histocompatibility loci.

Authors:  R L Walford
Journal:  Science       Date:  1966-04-01       Impact factor: 47.728

  6 in total
  96 in total

Review 1.  Transplantation tolerance, microchimerism, and the two-way paradigm.

Authors:  T E Starzl; A J Demetris
Journal:  Theor Med Bioeth       Date:  1998-09

2.  History of clinical transplantation.

Authors:  T E Starzl
Journal:  World J Surg       Date:  2000-07       Impact factor: 3.352

3.  High levels of Epstein-Barr virus DNA in blood of solid-organ transplant recipients and their value in predicting posttransplant lymphoproliferative disorders.

Authors:  F Baldanti; P Grossi; M Furione; L Simoncini; A Sarasini; P Comoli; R Maccario; R Fiocchi; G Gerna
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 4.  Rheumatoid arthritis, malignancy, and paraproteins.

Authors:  C Kelly; H Sykes
Journal:  Ann Rheum Dis       Date:  1990-09       Impact factor: 19.103

5.  Factors in the Development of Liver Transplantation.

Authors:  T E Starzl; S Iwatsuki; B W Shaw; R D Gordon; C Esquivel; S Todo; I Kam; S Lynch
Journal:  Transplant Proc       Date:  1985-10       Impact factor: 1.066

6.  Smooth muscle tumor arising de novo in a liver allograft: A case report.

Authors:  Howard Doyle; Andreas G Tzakis; Eduardo Yunis; Thomas E Starzl
Journal:  Clin Transplant       Date:  1991-02       Impact factor: 2.863

7.  Posttransplant lymphoproliferative disorders occurring under primary FK 506 immunosuppression.

Authors:  J Reyes; A Tzakis; M Green; B Nour; M Nalesnik; D Van Thiel; M Martin; M K Breinig; J J Fung; M Cooper
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

Review 8.  Immunotherapeutic options for Epstein-Barr virus-associated lymphoproliferative disease following transplantation.

Authors:  Donald R Shaffer; Cliona M Rooney; Stephen Gottschalk
Journal:  Immunotherapy       Date:  2010-09       Impact factor: 4.196

9.  EBV-related lymphoproliferative disease complicating therapy with the anti-CD2 monoclonal antibody, siplizumab, in patients with T-cell malignancies.

Authors:  Deirdre O'Mahony; John C Morris; Maryalice Stetler-Stevenson; Helen Matthews; Margaret R Brown; Thomas Fleisher; Stefania Pittaluga; Mark Raffeld; Paul S Albert; Dirk Reitsma; Karen Kaucic; Luz Hammershaimb; Thomas A Waldmann; John E Janik
Journal:  Clin Cancer Res       Date:  2009-03-17       Impact factor: 12.531

10.  Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern era.

Authors:  Andrew M Evens; Kevin A David; Irene Helenowski; Beverly Nelson; Dixon Kaufman; Sheetal M Kircher; Alla Gimelfarb; Elise Hattersley; Lauren A Mauro; Borko Jovanovic; Amy Chadburn; Patrick Stiff; Jane N Winter; Jayesh Mehta; Koen Van Besien; Stephanie Gregory; Leo I Gordon; Jamile M Shammo; Scott E Smith; Sonali M Smith
Journal:  J Clin Oncol       Date:  2010-01-19       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.